← Back to Search

Exercise for Kidney Failure

N/A

Recruiting

Led By Deborah Zimmerman, MD, MSc

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Able to understand English or French

Ambulatory adult patients with end stage kidney disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 months

Awards & highlights

Study Summary

This trial will test if an exercise intervention can help improve patient outcomes vs. the standard of care over a 3 year period.

Who is the study for?

This trial is for adults with end stage kidney disease who have been on dialysis for over six months, can walk, understand English or French, and are willing to use Nordic Walking poles. It's not suitable for those with conditions like unstable angina or uncontrolled high blood pressure, a daily step count over 8000 steps, an upcoming kidney transplant from a living donor, potential renal recovery, reliance on other mobility aids they feel unsafe replacing with walking poles, or participation in another conflicting trial.Check my eligibility

What is being tested?

The study tests if exercise helps people receiving chronic dialysis. Participants will be randomly assigned to either receive standard care or add an exercise program using Nordic Walking poles and online resources for one year. Their progress will be tracked with pedometers and encouraged by staff monthly.See study design

What are the potential side effects?

Since the intervention involves physical activity through prescribed exercises including Nordic Walking pole usage and monitoring via pedometer, side effects may include typical exercise-related issues such as muscle soreness or strain but should generally be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can understand English or French.

Select...

I have severe kidney disease and can walk.

Select...

I have been on dialysis for more than 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence

Recruitment Feasibility

Secondary outcome measures

Change in Living Status

Hand Grip Strength

Hospital Length of Stay

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Exercise InterventionExperimental Treatment1 Intervention

Participants in this arm will receive standard of care along with the exercise prescription intervention

Group II: Standard of CareActive Control1 Intervention

This group will receive standard of care treatment including regular verbal encouragement to exercise (monthly) by dialysis unit staff.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise Prescription

2009

N/A

~180

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor

561 Previous Clinical Trials

2,785,601 Total Patients Enrolled

2 Trials studying Kidney Failure

69 Patients Enrolled for Kidney Failure

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,341 Previous Clinical Trials

26,452,623 Total Patients Enrolled

3 Trials studying Kidney Failure

5,398 Patients Enrolled for Kidney Failure

Deborah Zimmerman, MD, MScPrincipal InvestigatorOttawa Hospital Research Institute

2 Previous Clinical Trials

26 Total Patients Enrolled

1 Trials studying Kidney Failure

14 Patients Enrolled for Kidney Failure

Media Library

Exercise Prescription Clinical Trial Eligibility Overview. Trial Name: NCT03787589 — N/A

Kidney Failure Research Study Groups: Exercise Intervention, Standard of Care

Kidney Failure Clinical Trial 2023: Exercise Prescription Highlights & Side Effects. Trial Name: NCT03787589 — N/A

Exercise Prescription 2023 Treatment Timeline for Medical Study. Trial Name: NCT03787589 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have enrolled in the experiment thus far?

"Affirmative. The information on clinicaltrials.gov confirms that this research project, which was initially publicized on April 15th 2019, is currently enrolling participants. Around 90 individuals must be admitted from a single medical centre."

Answered by AI

Are participants currently being accepted for this research endeavor?

"According to clinicaltrials.gov, this trial is still looking for participants and has been since April 15th 2019. The most recent update was made on September 29th 2022."

Answered by AI

What aims is this clinical trial attempting to achieve?

"This medical study, which has a duration of twelve months, will assess Recruitment Feasibility. Secondary aims include the assessment of Hand Grip Strength with a handgrip dynamometer in either the dominant or non-arteriovenous fistula arm (kgs), Change in Living Status - including full care and need for assistance such as housekeeping and meals; Hospital Length of Stay measured by average number of days spent in hospital."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise in Patients With End Stage Kidney Disease

2019. "Exercise in Patients With End Stage Kidney Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03787589.

All > Kidney Failure